Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial.

Yongxiang XiaWeiwei TangXiaofeng QianXiangcheng LiFeng ChengKe WangFeng ZhangChuanyong ZhangDonghua LiJinhua SongHui ZhangJie ZhaoAihua YaoXiaofeng WuChen WuGu-Wei JiXisheng LiuFeipeng ZhuLang QinXuan XiaoZhenhua DengXiangyi KongSi LiYangyang YuWenjing XiWanglong DengChuang QiHanyuan LiuLiyong PuPing WangXuehao Wang

Published in: Journal for immunotherapy of cancer (2022)

NCT04297202.

Keyphrases

phase ii
open label
clinical trial
phase iii
cardiac surgery
phase ii study
patients undergoing
study protocol
locally advanced
liver metastases
double blind
acute kidney injury
radiation therapy
squamous cell carcinoma